Medical Trade Shows in China — Page 2

Event overview

R&OC is organised around rehabilitation and independent living rather than general medical equipment. Its scope brings rehabilitation therapy systems together with mobility aids, assistive devices, prosthetics and orthotics, elderly-care products, physical testing and emergency-rescue equipment, so product comparison can follow a patient's movement and daily-living needs across settings.

The organiser's completed 2023 edition recorded nearly 10,000 visits, including about 300 overseas buyers from 22 countries and regions.

Event overview

Chengdu Medical and Health Expo brings clinical equipment, diagnostics, hospital infrastructure, rehabilitation and digital-health solutions into one western-China healthcare marketplace. Hospitals, distributors and care providers can use it to compare departmental equipment and service systems, rather than consumer wellness products with only a loose medical connection.

Event overview

COOC combines an ophthalmology and optometry congress with a specialist product exhibition. Diagnostic and imaging instruments, ophthalmic surgical technology, lenses and contact-lens systems, vision-testing equipment and clinical eye-care products are presented in a setting shaped by medical education and practice rather than general hospital procurement.

First held in Shanghai in 1999, COOC has developed a conference-led exhibition format linking clinical discussion with ophthalmic and optometric products.

Event overview

CIHIE Beijing is a broad health and wellness marketplace rather than a conventional clinical-device exhibition. Nutrition and health foods, traditional Chinese medicine and wellness products, home medical and rehabilitation supplies, organic foods, specialist edible oils and newer consumer health categories are grouped as themed exhibitions within one health-industry platform.

CIHIE was founded in 2003, has completed 35 editions and presents the 2027 Beijing event as its 36th edition.

Event overview

BioPh China is the biotechnology and bioprocessing part of the CPHI platform. Recombinant proteins, peptides, nucleic acids, vaccines, antibodies, cell and gene therapies and other emerging treatments sit with culture media, biological reagents, separation and purification systems, bioanalysis, bioinformatics and preclinical, clinical and contract R&D services.

It operates as the dedicated Biotech zone within CPHI & PMEC China, connecting drug candidates with the platforms and processes required to develop and manufacture them.

Event overview

CPHI & PMEC China connects pharmaceutical materials and development services with the machinery needed to manufacture and pack them. APIs, intermediates, excipients, finished dosage, biotech and CRO/CDMO services are presented alongside processing equipment, laboratory and clean technology, packaging and drug-delivery systems, allowing separate pharmaceutical workstreams to be researched in one event.

The 2027 show marks the event’s 25th-anniversary milestone and moves to the National Exhibition and Convention Center in Shanghai.